Jan 09, 2026
Media Highlights
PharmaVoice’s Crystal Ball: What’s next for AI and drug R&D
View on PharmaVoice
Media Center
Jan 02, 2026
Media Highlights
Long-acting anti-TSLP antibody for severe asthma moves into phase 3
View on Healio
Dec 09, 2025
Media Highlights
What will be the first AI-designed drug? These disease-fighting antibodies are top contenders
View on Nature
Dec 01, 2025
Media Highlights
Generate to launch Phase 3 TSLP drug studies, as AI bio enters its clinical era
View on Endpoints News
Dec 01, 2025
Media Highlights
Somerville biotech says its AI-created asthma drug will enter late-stage trials
View on Biz Journals
Oct 14, 2025
Media Highlights
Monoclonal antibody effects persist for 6 months in patients
View on Healio
Oct 14, 2025
Media Highlights
Benchtalk 2025: Generate:Biomedicines’ VP of Informatics Stephen Kottmann describes the investments in technology that ensures only the highest quality data returns back into its models
View on BiotechTV
Sep 22, 2025
Media Highlights
The Future of Medicine 2025: Boston’s breakthroughs in biotech
View on Boston Globe
Sep 09, 2025
Media Highlights
Best Workplaces for Innovators 2025: AI, automation, and machine learning excellence
View on Fast Company